tradingkey.logo

DENTSPLY SIRONA Inc

XRAY
11.210USD
-0.000-0.00%
Market hours ETQuotes delayed by 15 min
2.24BMarket Cap
LossP/E TTM

DENTSPLY SIRONA Inc

11.210
-0.000-0.00%

More Details of DENTSPLY SIRONA Inc Company

DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. It develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional-directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for urinary and bowel management.

DENTSPLY SIRONA Inc Info

Ticker SymbolXRAY
Company nameDENTSPLY SIRONA Inc
IPO dateAug 12, 1987
CEOScavilla (Daniel T)
Number of employees14000
Security typeOrdinary Share
Fiscal year-endAug 12
Address13320 Ballantyne Corporate Place
CityCHARLOTTE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code28277-3607
Phone18445463722
Websitehttps://www.dentsplysirona.com/
Ticker SymbolXRAY
IPO dateAug 12, 1987
CEOScavilla (Daniel T)

Company Executives of DENTSPLY SIRONA Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Willie A. Deese
Mr. Willie A. Deese
Independent Director
Independent Director
57.46K
+0.31%
Ms. Janet S. Vergis
Ms. Janet S. Vergis
Independent Director
Independent Director
44.30K
+0.41%
Mr. Clyde R. Hosein
Mr. Clyde R. Hosein
Independent Director
Independent Director
40.94K
+0.70%
Mr. Jonathan Jay Mazelsky
Mr. Jonathan Jay Mazelsky
Independent Director
Independent Director
34.29K
+1.06%
Mr. Brian T. Gladden
Mr. Brian T. Gladden
Independent Director
Independent Director
28.73K
+1.01%
Mr. Gregory T. (Greg) Lucier
Mr. Gregory T. (Greg) Lucier
Independent Chairman of the Board
Independent Chairman of the Board
21.02K
-79.63%
Mr. Michael J. (Mike) Barber, M.D.
Mr. Michael J. (Mike) Barber, M.D.
Independent Director
Independent Director
14.31K
+1.59%
Mr. Daniel T. (Dan) Scavilla
Mr. Daniel T. (Dan) Scavilla
President, Chief Executive Officer, Interim Principal Financial Officer, Director
President, Chief Executive Officer, Interim Principal Financial Officer, Director
14.31K
+1.59%
Mr. Aldo M. Denti
Mr. Aldo M. Denti
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
--
--
Mr. Kevin J. Czerney
Mr. Kevin J. Czerney
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Willie A. Deese
Mr. Willie A. Deese
Independent Director
Independent Director
57.46K
+0.31%
Ms. Janet S. Vergis
Ms. Janet S. Vergis
Independent Director
Independent Director
44.30K
+0.41%
Mr. Clyde R. Hosein
Mr. Clyde R. Hosein
Independent Director
Independent Director
40.94K
+0.70%
Mr. Jonathan Jay Mazelsky
Mr. Jonathan Jay Mazelsky
Independent Director
Independent Director
34.29K
+1.06%
Mr. Brian T. Gladden
Mr. Brian T. Gladden
Independent Director
Independent Director
28.73K
+1.01%
Mr. Gregory T. (Greg) Lucier
Mr. Gregory T. (Greg) Lucier
Independent Chairman of the Board
Independent Chairman of the Board
21.02K
-79.63%

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Implants & Prosthetics
163.00M
17.41%
Equipment & Instruments
136.00M
14.53%
CAD/CAM
107.00M
11.43%
Orthodontics
63.00M
6.73%
By RegionUSD
Name
Revenue
Proportion
Europe
404.00M
43.16%
United States
293.00M
31.30%
Rest of World
239.00M
25.53%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Implants & Prosthetics
163.00M
17.41%
Equipment & Instruments
136.00M
14.53%
CAD/CAM
107.00M
11.43%
Orthodontics
63.00M
6.73%

Shareholding Stats

Updated: Tue, Nov 18
Updated: Tue, Nov 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
10.97%
BlackRock Institutional Trust Company, N.A.
8.49%
First Eagle Investment Management, L.L.C.
7.11%
Fuller & Thaler Asset Management Inc.
6.40%
AQR Capital Management, LLC
6.26%
Other
60.76%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
10.97%
BlackRock Institutional Trust Company, N.A.
8.49%
First Eagle Investment Management, L.L.C.
7.11%
Fuller & Thaler Asset Management Inc.
6.40%
AQR Capital Management, LLC
6.26%
Other
60.76%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
46.79%
Investment Advisor
43.01%
Hedge Fund
12.26%
Research Firm
2.12%
Sovereign Wealth Fund
1.37%
Pension Fund
1.23%
Bank and Trust
0.63%
Family Office
0.45%
Individual Investor
0.36%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
1039
208.47M
104.47%
-37.39M
2025Q2
1076
202.86M
101.79%
-35.11M
2025Q1
1100
209.97M
105.36%
-34.15M
2024Q4
1116
212.15M
106.59%
-31.74M
2024Q3
1108
218.82M
107.90%
-27.75M
2024Q2
1114
221.52M
106.70%
-12.09M
2024Q1
1147
216.71M
104.34%
-22.65M
2023Q4
1167
223.33M
105.42%
-4.04M
2023Q3
1198
213.44M
100.81%
-18.52M
2023Q2
1222
214.75M
101.06%
-24.43M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
21.03M
10.54%
+396.42K
+1.92%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
16.83M
8.44%
-352.48K
-2.05%
Jun 30, 2025
First Eagle Investment Management, L.L.C.
14.19M
7.12%
-245.12K
-1.70%
Jun 30, 2025
Fuller & Thaler Asset Management Inc.
12.39M
6.21%
+315.57K
+2.61%
Jun 30, 2025
AQR Capital Management, LLC
13.32M
6.68%
+6.97M
+109.82%
Jun 30, 2025
Lazard Asset Management, L.L.C.
10.11M
5.07%
+745.42K
+7.96%
Jun 30, 2025
Cooke & Bieler, L.P.
9.15M
4.59%
-2.84K
-0.03%
Jun 30, 2025
State Street Investment Management (US)
7.10M
3.56%
+369.88K
+5.50%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
5.85M
2.93%
-1.10M
-15.85%
Jun 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
3D Printing ETF
6.25%
Brandes US Small-Mid Cap Value ETF
2.15%
State Street SPDR S&P Health Care Equipment ETF
1.64%
Royce Quant Small-Cap Quality Value ETF
0.49%
Invesco NASDAQ Future Gen 200 ETF
0.47%
AGF US Market Neutral Anti-Beta Fund
0.46%
VictoryShares Hedged Equity Income ETF
0.45%
Federated Hermes MDT Large Cap Value ETF
0.38%
WisdomTree U.S. SmallCap Dividend Fund
0.37%
Avantis US Small Cap Equity ETF
0.2%
View more
3D Printing ETF
Proportion6.25%
Brandes US Small-Mid Cap Value ETF
Proportion2.15%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.64%
Royce Quant Small-Cap Quality Value ETF
Proportion0.49%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.47%
AGF US Market Neutral Anti-Beta Fund
Proportion0.46%
VictoryShares Hedged Equity Income ETF
Proportion0.45%
Federated Hermes MDT Large Cap Value ETF
Proportion0.38%
WisdomTree U.S. SmallCap Dividend Fund
Proportion0.37%
Avantis US Small Cap Equity ETF
Proportion0.2%

Dividend

A total of 526.00M USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Aug 07, 2025
XRAY.NB Interim Cash Dividend of gross USD 0.16 paid on Oct 10, 2025 going ex on Sep 26, 2025
Sep 26, 2025
Oct 10, 2025
Sep 26, 2025
May 27, 2025
XRAY.NB Interim Cash Dividend of gross USD 0.16 paid on Jul 11, 2025 going ex on Jun 27, 2025
Jun 27, 2025
Jul 11, 2025
Jun 27, 2025
Feb 28, 2025
XRAY.NB Interim Cash Dividend of gross USD 0.16 paid on Apr 11, 2025 going ex on Mar 28, 2025
Mar 28, 2025
Apr 11, 2025
Mar 28, 2025
Dec 13, 2024
XRAY.NB Final Cash Dividend of gross USD 0.16 paid on Jan 10, 2025 going ex on Dec 27, 2024
Dec 27, 2024
Jan 10, 2025
Dec 27, 2024
Aug 01, 2024
XRAY.NB Interim Cash Dividend of gross USD 0.16 paid on Oct 11, 2024 going ex on Sep 27, 2024
Sep 27, 2024
Oct 11, 2024
Sep 27, 2024
May 22, 2024
XRAY.NB Interim Cash Dividend of gross USD 0.16 paid on Jul 12, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 12, 2024
Jun 28, 2024
Feb 29, 2024
XRAY.NB Interim Cash Dividend of gross USD 0.16 paid on Apr 12, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 12, 2024
Mar 27, 2024
Dec 21, 2023
XRAY.NB Final Cash Dividend of gross USD 0.14 paid on Jan 12, 2024 going ex on Dec 28, 2023
Dec 29, 2023
Jan 12, 2024
Dec 28, 2023
Aug 11, 2023
XRAY.NB Interim Cash Dividend of gross USD 0.14 paid on Oct 13, 2023 going ex on Sep 28, 2023
Sep 29, 2023
Oct 13, 2023
Sep 28, 2023
May 24, 2023
XRAY.NB Interim Cash Dividend of gross USD 0.14 paid on Jul 14, 2023 going ex on Jun 29, 2023
Jun 30, 2023
Jul 14, 2023
Jun 29, 2023
View more

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data

FAQs

Who are the top five shareholders of DENTSPLY SIRONA Inc?

The top five shareholders of DENTSPLY SIRONA Inc are:
The Vanguard Group, Inc. holds 21.03M shares, accounting for 10.54% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 16.83M shares, accounting for 8.44% of the total shares.
First Eagle Investment Management, L.L.C. holds 14.19M shares, accounting for 7.12% of the total shares.
Fuller & Thaler Asset Management Inc. holds 12.39M shares, accounting for 6.21% of the total shares.
AQR Capital Management, LLC holds 13.32M shares, accounting for 6.68% of the total shares.

What are the top three shareholder types of DENTSPLY SIRONA Inc?

The top three shareholder types of DENTSPLY SIRONA Inc are:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
First Eagle Investment Management, L.L.C.

How many institutions hold shares of DENTSPLY SIRONA Inc (XRAY)?

As of 2025Q3, 1039 institutions hold shares of DENTSPLY SIRONA Inc, with a combined market value of approximately 208.47M, accounting for 104.47% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 2.68%.

What is the biggest source of revenue for DENTSPLY SIRONA Inc?

In FY2025Q2, the Implants & Prosthetics business generated the highest revenue for DENTSPLY SIRONA Inc, amounting to 163.00M and accounting for 17.41% of total revenue.
KeyAI